OBJECTIVE: To determine the natural history and treatment of high-grade small bowel obstruction (HGSBO). Small bowel obstruction is a frequent complication of abdominal surgery. Complete and strangulating obstructions are managed operatively while partial obstructions receive a trial of nonoperative therapy. The management and outcome of patients with HGSBO diagnosed by computed tomography (CT) has not been examined. DESIGN: Retrospective medical record review. Outcomes for nonoperative vs operative management were analyzed using Fisher exact and log-rank tests. SETTING: Tertiary care referral center. PATIENTS: One thousand five hundred sixty-eight consecutive patients admitted from the emergency department with a diagnosis of small bowel obstruction between 2000 and 2005 by CT criteria. MAIN OUTCOME MEASURES: Recurrence of symptoms and complications. RESULTS: One hundred forty-five patients (9%) with HGSBO were identified, with 88% follow-up (median, 332 days; range, 4-2067 days). Sixty-six (46%) were successfully managed nonoperatively while 79 (54%) required an operation. Length of stay and complications were significantly increased in the operative group (4.7 days vs 10.8 days and 3% vs 23%; P < .001). Nonoperative management was associated with a higher recurrence rate (24% vs 9%; P < .005) and shorter time to recurrence (39 days vs 105 days; P < .005) compared with operative intervention. Computed tomography signs of ischemia, admission laboratory results, and presence of cancer or inflammatory bowel disease were not predictive of an operation. CONCLUSIONS: Patients with HGSBO by CT can be managed safely with nonoperative therapy; however, they have a significantly higher rate of recurrence requiring readmission or operation within 5 years.
OBJECTIVE: To determine the natural history and treatment of high-grade small bowel obstruction (HGSBO). Small bowel obstruction is a frequent complication of abdominal surgery. Complete and strangulating obstructions are managed operatively while partial obstructions receive a trial of nonoperative therapy. The management and outcome of patients with HGSBO diagnosed by computed tomography (CT) has not been examined. DESIGN: Retrospective medical record review. Outcomes for nonoperative vs operative management were analyzed using Fisher exact and log-rank tests. SETTING: Tertiary care referral center. PATIENTS: One thousand five hundred sixty-eight consecutive patients admitted from the emergency department with a diagnosis of small bowel obstruction between 2000 and 2005 by CT criteria. MAIN OUTCOME MEASURES: Recurrence of symptoms and complications. RESULTS: One hundred forty-five patients (9%) with HGSBO were identified, with 88% follow-up (median, 332 days; range, 4-2067 days). Sixty-six (46%) were successfully managed nonoperatively while 79 (54%) required an operation. Length of stay and complications were significantly increased in the operative group (4.7 days vs 10.8 days and 3% vs 23%; P < .001). Nonoperative management was associated with a higher recurrence rate (24% vs 9%; P < .005) and shorter time to recurrence (39 days vs 105 days; P < .005) compared with operative intervention. Computed tomography signs of ischemia, admission laboratory results, and presence of cancer or inflammatory bowel disease were not predictive of an operation. CONCLUSIONS:Patients with HGSBO by CT can be managed safely with nonoperative therapy; however, they have a significantly higher rate of recurrence requiring readmission or operation within 5 years.
Authors: Theunis J van Zyl; Patrick B Murphy; Laura Allen; Neil G Parry; Ken Leslie; Kelly N Vogt Journal: Can J Surg Date: 2018-08 Impact factor: 2.089
Authors: Martin D Zielinski; Patrick W Eiken; Michael P Bannon; Stephanie F Heller; Christine M Lohse; Marianne Huebner; Michael G Sarr Journal: World J Surg Date: 2010-05 Impact factor: 3.352
Authors: Lucas W Thornblade; Francys C Verdial; Matthew A Bartek; David R Flum; Giana H Davidson Journal: J Gastrointest Surg Date: 2019-02-20 Impact factor: 3.452
Authors: C J van Beekum; B Stoffels; M von Websky; J Dohmen; C J J Paul; J C Kalff; T O Vilz Journal: Med Klin Intensivmed Notfmed Date: 2019-12-02 Impact factor: 0.840
Authors: Andrew J Medvecz; Bradley M Dennis; Li Wang; Christopher J Lindsell; Oscar D Guillamondegui Journal: J Am Coll Surg Date: 2020-01-17 Impact factor: 6.113
Authors: Theunis J van Zyl; Patrick B Murphy; Laura Allen; Neil G Parry; Ken Leslie; Kelly N Vogt Journal: Can J Surg Date: 2018-06-01 Impact factor: 2.089
Authors: Rachel S Morris; Patrick Murphy; Kelly Boyle; Louis Somberg; Travis Webb; David Milia; Christopher J Tignanelli; Marc de Moya; Colleen Trevino Journal: Am Surg Date: 2021-01-27 Impact factor: 1.002